Growing community of inventors

Palo Alto, CA, United States of America

Xiaomei Zhang

Average Co-Inventor Count = 3.84

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 38

Xiaomei ZhangCharles T Esmon (4 patents)Xiaomei ZhangRahim Mohamed Yaseen (4 patents)Xiaomei ZhangJun Xu (4 patents)Xiaomei ZhangSean K Frogner (3 patents)Xiaomei ZhangMichael Fortson (3 patents)Xiaomei ZhangHasan Rizvi (3 patents)Xiaomei ZhangMuruganantham Chinnananchi (3 patents)Xiaomei ZhangJohn Liang (1 patent)Xiaomei ZhangYunhee Choi (1 patent)Xiaomei ZhangJun Xu (1 patent)Xiaomei ZhangXiaomei Zhang (8 patents)Charles T EsmonCharles T Esmon (29 patents)Rahim Mohamed YaseenRahim Mohamed Yaseen (27 patents)Jun XuJun Xu (7 patents)Sean K FrognerSean K Frogner (4 patents)Michael FortsonMichael Fortson (4 patents)Hasan RizviHasan Rizvi (4 patents)Muruganantham ChinnananchiMuruganantham Chinnananchi (3 patents)John LiangJohn Liang (7 patents)Yunhee ChoiYunhee Choi (1 patent)Jun XuJun Xu (19 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Oklahoma Medical Research Foundation (4 from 197 patents)

2. Servicenow, Inc. (3 from 1,066 patents)

3. Oracle International Corporation (1 from 11,307 patents)


8 patents:

1. 11458187 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy

2. 11409425 - Transactional conversation-based computing system

3. 10466885 - Transactional conversation-based computing system

4. 10452251 - Transactional conversation-based computing system

5. 10350261 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy

6. 10238711 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy

7. 9535663 - Pattern-based construction and extension of enterprise applications in a cloud computing environment

8. 8716218 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…